EESMO Open3/17/2026467P HERV-K as a shared tumor antigen in non-small cell lung cancer (NSCLC): Rationale for immunotherapy and checkpoint blockade combinationMaria Perez-Penco·P.J. Holst·M.D. Müller·C. Picon-Jara·K. Staal Rohrberg·E. Ragonnaud·A-M. Andersson·E. Sofie Engdal·Frederik Otzen Bagger·L. Neukirch·T.B.B. GazielRead at ESMO OpenTagsChromosomal and Genetic VariationsPlant Science
